Intravenous ketamine for suicide ideation in borderline personality and depression.
L'Encephale August 1, 2025 Yara Bachir, Raymond Kassab, C. Hallal et al.
OBJECTIVE This case report explores the efficacy of intravenous Ketamine in treating active suicidal ideation in a 24-year-old female with comorbid major depressive disorder (MDD), borderline personality disorder (BPD), posttraumatic stress disorder (PTSD), and functional neurological disorder (FND). CASE DESCRIPTION The patient, with a history of multiple suicide attempts and...